IL100415A0 - Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases - Google Patents

Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases

Info

Publication number
IL100415A0
IL100415A0 IL100415A IL10041591A IL100415A0 IL 100415 A0 IL100415 A0 IL 100415A0 IL 100415 A IL100415 A IL 100415A IL 10041591 A IL10041591 A IL 10041591A IL 100415 A0 IL100415 A0 IL 100415A0
Authority
IL
Israel
Prior art keywords
pulmonary diseases
alpha interferon
oral inhalation
treat asthma
malignant proliferative
Prior art date
Application number
IL100415A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL100415A0 publication Critical patent/IL100415A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL100415A 1990-12-21 1991-12-18 Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases IL100415A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63156590A 1990-12-21 1990-12-21
US63155290A 1990-12-21 1990-12-21

Publications (1)

Publication Number Publication Date
IL100415A0 true IL100415A0 (en) 1992-09-06

Family

ID=27091422

Family Applications (1)

Application Number Title Priority Date Filing Date
IL100415A IL100415A0 (en) 1990-12-21 1991-12-18 Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases

Country Status (6)

Country Link
AU (1) AU9132091A (fr)
IE (1) IE914444A1 (fr)
IL (1) IL100415A0 (fr)
MX (1) MX9102702A (fr)
PT (1) PT99837A (fr)
WO (1) WO1992011025A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271206B1 (en) 1996-09-12 2001-08-07 Valentis, Inc. Sonic nebulized nucleic acid/cationic liposome complexes and methods for pulmonary gene delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028422A (en) * 1986-05-27 1991-07-02 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
AU601741B2 (en) * 1986-05-27 1990-09-20 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
ES2052579T3 (es) * 1986-10-22 1994-07-16 Schering Corp Empleo de interferon alfa humano recombinante para la fabricacion de un medicamento para tratar el virus del sida.
WO1988009673A1 (fr) * 1987-06-02 1988-12-15 Schering Corporation Traitement de l'hepatite b de type chronique avec une combinaison d'interferons alpha et gamma humains recombinants
JPH0618784B2 (ja) * 1988-07-05 1994-03-16 シェリング・コーポレーション ポドフィリンと組換えｄｎａヒト・アルファ・インターフェロンの併用による生殖器イボの治療
US4959210A (en) * 1988-11-01 1990-09-25 Schering Corporation Treatment of genital warts with a combination of liquid nitrogen and recombinant DNA human alpha interferon
AU634511B2 (en) * 1988-12-01 1993-02-25 Schering Corporation Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon

Also Published As

Publication number Publication date
MX9102702A (es) 1992-06-01
WO1992011025A2 (fr) 1992-07-09
WO1992011025A3 (fr) 1992-09-17
PT99837A (pt) 1992-12-31
AU9132091A (en) 1992-07-22
IE914444A1 (en) 1992-07-01

Similar Documents

Publication Publication Date Title
US5018519B1 (en) Mask for administering an anesthetic gas to a patient
HUT67534A (en) Medicaments for inhalation and canister suitable for stoning and delivering these medicaments
IL107518A0 (en) Therapeutic and diagnostic compositions comprising purified surface modifiers to prevent particle aggregation during sterilization
GR3032207T3 (en) 2-Bromomelatonin in the therapy of sleep disorders
PL340994A1 (en) Method of administering therapeutic substances by inhalation and inhaler therefor
IT8547939A1 (it) Liposomi contenenti interleucina metodo per la loro preparazione e loro uso terapeutico nelle affezioni tumorali
HK1018595A1 (en) Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis
IL78913A (en) Synthetic vaccines for foot and mouth disease,their preparation and use
IL100332A0 (en) Oral administration of alpha interferon to treat lung malignancies
GB2235627B (en) Inhalation medicaments for treating respiratory disorders
IL100415A0 (en) Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
ZA919959B (en) Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
IL65184A (en) Preparation comprising glycyrrhizin for the treatment of dermal,including oral diseases
TW263437B (fr)
DE3470002D1 (en) Use of l-fucose in the preparation of an inhalation composition and a process for preparing l-fucose
GB2170403B (en) Medicament for treatment of asthma and preparation thereof
EP0267684A3 (en) Human leukocyte interferon composition and skin treatment
ZA903044B (en) Interferon for the use in the prevention or treatment of swine pneumonia or related bacterial diseases
PL316444A1 (en) Novel agent against viral diseases of respiratory tracts
GB9124275D0 (en) New radical scavenging and antilipoperoxidant flavanolignans their preparation and formulations for therapeutic use
HK1005735A1 (en) Perhydrothiazepine and perhydroazepine derivatives their preparation and their therapeutic use
ZA852632B (en) Perhydrothiazepine derivatives,their preparation and their therapeutic use
IL84777A0 (en) Prevention of bovine respiratory disease complex in cattle by administration of interferon
PL284057A1 (en) Oral and nasal inhaler
DE3173229D1 (en) Inhalation spirometric device for administering pulmonary medication